Quote:
Well, investors are interpreting Fiddler's purchase -- the first open-market purchase by a member of management in years -- as a big vote of confidence from Solazyme's top brass at a time when it's needed most. The 80,000 shares had a market value of roughly $216,000. That may be dwarfed by the $1.94 million in shares he sold through trading plans in 2014, but investors are focusing on the fact that shares were accumulated rather than disposed.
Perhaps the director is trying to pump up the stock price so he can sell off more shares.
So the asshole brings down the share price throughout 2014 only to buy back 15% the next year trying to pump it up again?